{
    "nct_id": "NCT06444412",
    "official_title": "GA-68 PSMA-11 PET to Evaluate Malignant Glioma Recurrence - a Pilot Study",
    "inclusion_criteria": "* Age â‰¥ 18 years.\n* History of World Health Organization (WHO) grade III or IV infiltrating glioma previously treated with first-line chemoradiotherapy.\n* MRI findings compatible with contrast-enhancing recurrent infiltrating glioma.\n* Planned craniotomy for resection of suspected disease recurrence.\n* Willing to sign release of information for any radiation and/or follow-up records.\n* Ability to provide informed written consent.\n* Ability to provide tissue for mandatory correlative research component.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Previous treatment with antiangiogenic therapy (e.g. bevacizumab).\n* Unable to undergo a PSMA PET/CT scan (e.g. body habitus, claustrophobia).\n* Any of the following:\n\n  * Pregnant women\n  * Nursing women\n  * Men or women of childbearing potential unwilling to employ adequate contraception",
    "miscellaneous_criteria": ""
}